Laboratory of Epigenetics, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
Department of Pathology, Seoul National University College of Medicine, Seoul, South Korea.
Histopathology. 2018 Oct;73(4):663-671. doi: 10.1111/his.13674. Epub 2018 Jul 26.
The role of tumour-associated macrophages (TAMs) in colorectal cancer (CRC) remains elusive. In this study, we aimed to examine the correlation between TAMs, clinicopathological features, tumour-infiltrating lymphocytes (TILs) and prognosis in CRC by the use of image analysis.
Immunohistochemical staining for CD68 and CD163 was performed as pan-macrophage and M2-macrophage markers, respectively. Each marker was analysed separately for intra-epithelial and stromal area densities. All four macrophage densities showed a significant correlation with one another (P = 0.001). Intra-epithelial CD68 macrophage densities showed a correlation with pTNM stage (P = 0.008), microsatellite instability (MSI) (P < 0.001), CpG island methylator phenotype (CIMP) (P < 0.001) and TIL densities (P < 0.001). Intra-epithelial CD163 macrophage densities were associated with perineural invasion, MSI, CIMP and TIL densities (P < 0.001). Stromal CD68 and CD163 macrophage densities had a significant relationship with intra-epithelial and stromal CD3 (P = 0.001 and P < 0.001, respectively) and CD8 (P < 0.001) T cells. High intra-epithelial CD68 macrophage density was associated with worse overall survival (HR = 1.386, 95% CI = 1.043-1.843, P = 0.025) and progression-free survival (HR = 1.522, 95% CI = 1.146-2.020, P = 0.004). Intra-epithelial CD68 macrophage density was also an independent prognostic factor of the progression-free survival (HR = 1.447, 95% CI = 1.076-1.947, P = 0.015) of CRC patients regardless of pTNM stage, lymphatic, venous, and perineural invasions and TIL densities.
Our results indicate that the density of intratumoural macrophages is a useful prognostic indicator for further stratifying T cell populations in CRC.
肿瘤相关巨噬细胞(TAMs)在结直肠癌(CRC)中的作用仍不清楚。在本研究中,我们旨在通过图像分析检查 TAMs、临床病理特征、肿瘤浸润淋巴细胞(TILs)与 CRC 预后之间的相关性。
分别使用 CD68 和 CD163 免疫组织化学染色作为泛巨噬细胞和 M2 巨噬细胞标志物进行检测。分别分析每个标志物的上皮内和基质区域密度。所有四种巨噬细胞密度均存在显著相关性(P=0.001)。上皮内 CD68 巨噬细胞密度与 pTNM 分期(P=0.008)、微卫星不稳定性(MSI)(P<0.001)、CpG 岛甲基化表型(CIMP)(P<0.001)和 TIL 密度(P<0.001)相关。上皮内 CD163 巨噬细胞密度与神经周围侵犯、MSI、CIMP 和 TIL 密度相关(P<0.001)。基质 CD68 和 CD163 巨噬细胞密度与上皮内和基质 CD3(P=0.001 和 P<0.001)和 CD8(P<0.001)T 细胞有显著关系。上皮内 CD68 巨噬细胞密度高与总生存(HR=1.386,95%CI=1.043-1.843,P=0.025)和无进展生存(HR=1.522,95%CI=1.146-2.020,P=0.004)不良相关。上皮内 CD68 巨噬细胞密度也是 CRC 患者无进展生存的独立预后因素(HR=1.447,95%CI=1.076-1.947,P=0.015),无论 pTNM 分期、淋巴、静脉和神经周围侵犯以及 TIL 密度如何。
我们的结果表明,肿瘤内巨噬细胞的密度是进一步分层 CRC 中 T 细胞群体的有用预后指标。